China’s NMPA Approves Innovent’s Anti-PD-1 Antibody Tyvyt® (Sintilimab injection) for Hodgkin’s Lymphoma Dec 27, 2018 Life Science
Calif ornia-Based Opiant Licenses Synthetic Cannabinoid Overdose Drug From Sanofi for $500,000 Dec 27, 2018 Cannabis, Life Science
Rakuten Aspyrian Closes $284 Million Series C Financing for Late-Stage Oncology Pipeline Dec 24, 2018 Life Science
Xynomic Pharmaceuticals Picks up Second Cancer Drug From Boehringer Ingelheim in $800 Million Deal Dec 21, 2018 Life Science
Gan & Lee and a Leading Pharmaceutical Company Enters into Global Collaboration to Commercialize Insulin Analog Dec 21, 2018 Life Science
Chi-Med Announces Amendment to the 2013 License & Collaboration Agreement on Fruquintinib with Eli Lilly and Company Dec 20, 2018 Life Science
AC Immune and WuXi Biologics to Establish an Exclusive Strategic Partnership Dec 19, 2018 Life Science
Mobidiag Announces Joint Venture with Autobio Diagnostics and €10m Equity Investment Dec 19, 2018 Life Science
Lee’s Pharm Enters $22.5 Million Deal for AI-Discovered Preclinical Molecule Dec 19, 2018 Life Science
Junshi Biosciences’s Tuoyi is First China-Developed Anti-PD-1 Drug Approved for Marketing Dec 19, 2018 Life Science
Roxadustat approved in China for the treatment of anaemia in chronic kidney disease patients on dialysis Dec 18, 2018 Life Science
